Clinical Trials · NCT06388187
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 300
- Start date
- Jun 2024
- Locations
- 25 sites, 5 countries
- Primary endpoint
- Relative change in body weight